Fibrinolysis in pre-eclampsia

[1]  R. Mattaliano,et al.  Purification and characterization of a plasminogen activator inhibitor from the histiocytic lymphoma cell line U-937. , 1986, The Journal of biological chemistry.

[2]  J. Paramo,et al.  Inhibition of one-chain and two-chain forms of human tissue-type plasminogen activator by the fast-acting inhibitor of plasminogen activator in vitro and in vivo. , 1986, The Journal of laboratory and clinical medicine.

[3]  J. Gilabert,et al.  Fibrinolytic Activity and Protein C in Preeclampsia , 1986, Thrombosis and Haemostasis.

[4]  L. Häggroth,et al.  Plasminogen activator inhibitors in plasma and platelets from patients with recurrent venous thrombosis and pregnant women. , 1986, Thrombosis research.

[5]  J. Zeuthen,et al.  Immunological Relationship Between the Fast-Acting Plasminogen Activator Inhibitors from Plasma, Blood Platelets and Endothelial Cells Demonstrated with a Monoclonal Antibody Against an Inhibitor from Placenta , 1986, Thrombosis and Haemostasis.

[6]  B. Åstedt,et al.  Isolation of a new specific plasminogen activator in hibitor from pregnancy plasma , 1986, British journal of haematology.

[7]  I. Nilsson,et al.  Different types of plasminogen activator inhibitors in plasma and platelets in pregnant women , 1986, British journal of haematology.

[8]  D. Loskutoff,et al.  The primary plasminogen-activator inhibitors in endothelial cells, platelets, serum, and plasma are immunologically related. , 1985, Proceedings of the National Academy of Sciences of the United States of America.

[9]  B. Åstedt,et al.  Different inhibition of one and two chain tissue plasminogen activator by a placental inhibitor studied with two tripeptide-p-nitroanilide substrates. , 1985, Scandinavian journal of clinical and laboratory investigation.

[10]  E. Kruithof,et al.  Human tissue-type plasminogen activator. Production in continuous serum-free cell culture and rapid purification. , 1985, The Biochemical journal.

[11]  W. Hauck,et al.  Antithrombin III Activity in Women With Hypertension During Pregnancy , 1985, Obstetrics and gynecology.

[12]  C. Arocha-Piñango,et al.  BETA‐THROMBOGLOBULIN (β‐TG) AND PLATELET FACTOR 4 (PF4) IN OBSTETRICAL CASES , 1985 .

[13]  D. Lawrence,et al.  Purification of an inhibitor of plasminogen activator (antiactivator) synthesized by endothelial cells. , 1984, The Journal of biological chemistry.

[14]  B. Wiman,et al.  The Fast Inhibitor of Tissue Plasminogen Activator in Plasma During Pregnancy , 1984, Thrombosis and Haemostasis.

[15]  R. Roblin,et al.  Differential inhibition of two molecular forms of melanoma cell plasminogen activator by a placental inhibitor , 1984, British journal of haematology.

[16]  H. Graeff,et al.  Recent aspects of hemostasis, hematology and hemorheology in preeclampsia-eclampsia. , 1984, European journal of obstetrics, gynecology, and reproductive biology.

[17]  J. T. ten Cate,et al.  Antithrombin III levels in preeclampsia correlate with maternal and fetal morbidity. , 1984, American journal of obstetrics and gynecology.

[18]  J. Weitz,et al.  Fibrinogen proteolysis and platelet alpha-granule release in preeclampsia/eclampsia. , 1984, Blood.

[19]  P. Wallén,et al.  An Enzyme Linked Immunosorbent Assay for Determination of Tissue Plasminogen Activator Applied to Patients with Thromboembolic Disease , 1983, Thrombosis and Haemostasis.

[20]  D. Ogston,et al.  Blood levels of proteinase inhibitors in pre‐eclampsia , 1983, British journal of obstetrics and gynaecology.

[21]  B. Wiman,et al.  Evidence for a rapid inhibitor to tissue plasminogen activator in plasma. , 1983, Thrombosis research.

[22]  J. Kelton,et al.  Thrombocytopenia in Preeclampsia and Eclampsia , 1982, Seminars in thrombosis and hemostasis.

[23]  J. Stuart,et al.  Haemostatic and rheological changes in normal pregnancy and pre‐eclampsia , 1982, British journal of haematology.

[24]  D. Collen,et al.  Purification and characterization of the plasminogen activator secreted by human melanoma cells in culture. , 1981, The Journal of biological chemistry.

[25]  A. Granelli‐Piperno,et al.  A study of proteases and protease-inhibitor complexes in biological fluids , 1978, The Journal of experimental medicine.

[26]  A. Teger‐Nilsson,et al.  Determination of a new rapid plasmin inhibitor in human blood by means of a plasmin specific tripeptide substrate. , 1977, Scandinavian journal of clinical and laboratory investigation.

[27]  D. Ogston,et al.  SEQUENTIAL STUDIES ON COMPONENTS OF THE HAEMOSTATIC MECHANISM IN PREGNANCY WITH PARTICULAR REFERENCE TO THE DEVELOPMENT OF PRE‐ECLAMPSIA , 1976, British journal of obstetrics and gynaecology.

[28]  D. Deutsch,et al.  Plasminogen: Purification from Human Plasma by Affinity Chromatography , 1970, Science.

[29]  E. Kruithof,et al.  Fibrinolysis in pregnancy , 1986 .

[30]  B. Wiman,et al.  A novel fast inhibitor to tissue plasminogen activator in plasma, which may be of great pathophysiological significance. , 1985, Scandinavian journal of clinical and laboratory investigation. Supplementum.

[31]  T. Terao,et al.  The role of placental urokinase inhibitor in toxemia of pregnancy. , 1983, Biological research in pregnancy and perinatology.

[32]  M. Maki.  Coagulation, fibrinolysis, platelet and kinin-forming systems during toxemia of pregnancy. , 1983, Biological research in pregnancy and perinatology.

[33]  G. Claeson,et al.  Methods for the Determination of Plasmin, Antiplasmin and Plasminogen by Means of the Substrate S-2251 , 1977, Thrombosis and Haemostasis.